Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions

Chronic Pain

The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation

Expert Opin Pharmacother.

Leppert W, Zajaczkowska R, Wordliczek J

doi: 10.1080/14656566.

Chronic Pain

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Pain.

Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC

doi: 10.1097/

HIV / AIDS

Escitalopram population pharmacokinetics in people living with HIV and in the psychiatric population: drug-drug interactions and probability of target attainment

Br J Clin Pharmacol.

Courlet P, Guidi M, Glatard A, Alves Saldanha S, Cavassini M, Buclin T, Marzolini C, Eap CB, Decosterd LA, Csajka C, Swiss HIV Cohort Study.

doi: 10.1111/bcp.13994.

Pain Management

The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain

Pain Med.

Gupta A, Coyne KS, Datto C, Venuti C

doi: 10.1093/pm/pny002.

Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial

Pain Med.

Webster LR, Michna E, Khan A, Israel RJ, Harper JR

doi: 10.1093/pm/pnx148.

Back Pain

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

J Pain Res.

Webster LR, Israel RJ

doi: 10.2147/JPR.S160488.

Chronic PainFibromyalgia

Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls-antagonistic effects between opioid and serotonin-related genes

Pain.

Tour J, Löfgren M, Mannerkorpi K, Gerdle B, Larsson A, Palstam A, Bileviciute-Ljungar I, Bjersing J, Martin I, Ernberg M, Schalling M, Kosek E

doi: 10.1097/j.pain.

Neuropathic PainPain Management

Nerve injury-induced epigenetic silencing of opioid receptors controlled by DNMT3a in primary afferent neurons

Pain.

Sun L, Zhao JY, Gu X, Liang L, Wu S, Mo K, Feng J, Guo W, Zhang J, Bekker A, Zhao X, Nestler EJ, Tao YX

doi: 10.1097/j.pain.

Neuropathic Pain

Role of peripheral sensory neuron mu-opioid receptors in nociceptive, inflammatory, and neuropathic pain

Reg Anesth Pain Med.

Barpujari A, Ford N, He SQ, Huang Q, Gaveriaux-Ruff C, Dong X, Guan Y, Raja S

doi: 10.1136/rapm-2020-101779.

Related content

The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Escitalopram population pharmacokinetics in people living with HIV and in the psychiatric population: drug-drug interactions and probability of target attainment

The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain

Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls-antagonistic effects between opioid and serotonin-related genes

Nerve injury-induced epigenetic silencing of opioid receptors controlled by DNMT3a in primary afferent neurons

Role of peripheral sensory neuron mu-opioid receptors in nociceptive, inflammatory, and neuropathic pain